
Valerie Rodriguez-garcia
Examiner (ID: 32, Phone: (571)270-5865 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1759, 1626, 1622 |
| Total Applications | 1118 |
| Issued Applications | 736 |
| Pending Applications | 90 |
| Abandoned Applications | 322 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17473901
[patent_doc_number] => 20220081405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => METHOD FOR PREPARING DISELENIDE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/290894
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290894 | Method for preparing diselenide compound | Jun 17, 2020 | Issued |
Array
(
[id] => 17913207
[patent_doc_number] => 20220315602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PYRAZOLE AND IMIDAZOLE DERIVATIVES, COMPOSITIONS AND METHODS AS OREXIN ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/616142
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616142 | PYRAZOLE AND IMIDAZOLE DERIVATIVES, COMPOSITIONS AND METHODS AS OREXIN ANTAGONISTS | Jun 2, 2020 | Pending |
Array
(
[id] => 17704506
[patent_doc_number] => 20220204512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => SUBSTITUTED FUSED BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINES
[patent_app_type] => utility
[patent_app_number] => 17/595533
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595533 | SUBSTITUTED FUSED BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINES | May 21, 2020 | Abandoned |
Array
(
[id] => 17548020
[patent_doc_number] => 20220119361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => 3-AMINO-4H-BENZO[E][1,2,4]THIADIAZINE 1,1-DIOXIDE DERIVATIVES AS INHIBITORS OF MRGX2
[patent_app_type] => utility
[patent_app_number] => 17/605962
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605962 | 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2 | Apr 27, 2020 | Issued |
Array
(
[id] => 17625708
[patent_doc_number] => 20220160723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PHARMACOLOGICAL MITIGATION OF LATE-STAGE TOXEMIA
[patent_app_type] => utility
[patent_app_number] => 17/602700
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602700 | PHARMACOLOGICAL MITIGATION OF LATE-STAGE TOXEMIA | Apr 19, 2020 | Abandoned |
Array
(
[id] => 17378095
[patent_doc_number] => 11236092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/843408
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 30129
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843408 | Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors | Apr 7, 2020 | Issued |
Array
(
[id] => 17608955
[patent_doc_number] => 20220151234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NOVEL OXADIAZOLE COMPOUNDS FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI
[patent_app_type] => utility
[patent_app_number] => 17/594216
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594216
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594216 | NOVEL OXADIAZOLE COMPOUNDS FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI | Apr 6, 2020 | Pending |
Array
(
[id] => 17657001
[patent_doc_number] => 20220177466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => DEGRADERS OF KELCH-LIKE ECH-ASSOCIATED PROTEIN 1 (KEAP1)
[patent_app_type] => utility
[patent_app_number] => 17/601536
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601536 | DEGRADERS OF KELCH-LIKE ECH-ASSOCIATED PROTEIN 1 (KEAP1) | Apr 6, 2020 | Abandoned |
Array
(
[id] => 17609785
[patent_doc_number] => 20220152064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => BENZOAZEPINE COMPOUND-CONTAINING PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/439061
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439061 | BENZOAZEPINE COMPOUND-CONTAINING PHARMACEUTICAL COMPOSITION | Mar 26, 2020 | Abandoned |
Array
(
[id] => 18134708
[patent_doc_number] => 11560361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Simplified structural mimetics of AIPS as quorum sensing inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/828412
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 21708
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16828412
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/828412 | Simplified structural mimetics of AIPS as quorum sensing inhibitors | Mar 23, 2020 | Issued |
Array
(
[id] => 16272587
[patent_doc_number] => 20200274075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/810626
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 789
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16810626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/810626 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Mar 4, 2020 | Pending |
Array
(
[id] => 16086775
[patent_doc_number] => 20200197374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => METHODS FOR TREATING PROTEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 16/807102
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807102
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807102 | METHODS FOR TREATING PROTEINOPATHIES | Mar 1, 2020 | Pending |
Array
(
[id] => 17576859
[patent_doc_number] => 20220133714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => EXTRACELLULAR MATRIX MODULATING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/430068
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430068
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430068 | EXTRACELLULAR MATRIX MODULATING AGENT | Feb 26, 2020 | Pending |
Array
(
[id] => 15993207
[patent_doc_number] => 20200172474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS
[patent_app_type] => utility
[patent_app_number] => 16/781106
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16781106
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/781106 | Alcohol derivatives as KV7 potassium channel openers | Feb 3, 2020 | Issued |
Array
(
[id] => 19012943
[patent_doc_number] => 11919858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
[patent_app_type] => utility
[patent_app_number] => 16/740167
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22351
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/740167 | Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases | Jan 9, 2020 | Issued |
Array
(
[id] => 15865991
[patent_doc_number] => 20200140399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => DIARYL CARBONATE AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING AN AROMATIC POLYCARBONATE RESIN
[patent_app_type] => utility
[patent_app_number] => 16/738226
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16738226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/738226 | Diaryl carbonate and method for producing the same, and method for producing an aromatic polycarbonate resin | Jan 8, 2020 | Issued |
Array
(
[id] => 16985456
[patent_doc_number] => 11072612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => NLRP3 modulators
[patent_app_type] => utility
[patent_app_number] => 16/703974
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24516
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703974 | NLRP3 modulators | Dec 4, 2019 | Issued |
Array
(
[id] => 17214416
[patent_doc_number] => 20210347753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => PROCESS FOR PREPARING GLYCOLIDE
[patent_app_type] => utility
[patent_app_number] => 17/287138
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287138 | Process for preparing glycolide | Nov 28, 2019 | Issued |
Array
(
[id] => 17808731
[patent_doc_number] => 20220260566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => IMMUNITY MECHANISM AND THERAPEUTIC DRUG FOR GASTROINTESTINAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/416918
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416918 | IMMUNITY MECHANISM AND THERAPEUTIC DRUG FOR GASTROINTESTINAL DISEASES | Nov 14, 2019 | Abandoned |
Array
(
[id] => 15963049
[patent_doc_number] => 20200165276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => NITROGEN-CONTAINING CYCLIC ORGANOXYSILANE COMPOUND AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/684283
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/684283 | Nitrogen-containing cyclic organoxysilane compound and method for producing the same | Nov 13, 2019 | Issued |